Literature DB >> 7522130

FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal.

S Metcalfe1, D Alexander, J Turner.   

Abstract

Antigen-specific signal transduction leading to IL2 induction and secretion in the T cell line 171 is augmented by association of p56lck with CD4. Although no change in cytoplasmic calcium level ([Ca2+]i) was detectable during antigen-specific signal transduction of 171-CD4+ cells, IL2 induction was inhibited by FK506 and CsA. Since these drugs are thought to act selectively by inhibiting calcineurin, a calcium-calmodulin-dependent protein phosphatase associated with activation of the IL2 promoter, we considered the possibility that calcineurin is constitutively active in 171 cells. However, we found no evidence for this because PMA failed to supplement any putatively active calcineurin to induce IL2 secretion. We suggest that IL2 secretion induced by antigen presentation to TCR/CD4/p56lck requires an FK506 and cyclosporin A-sensitive step which may be independent of calcium signaling. Rapamycin did not inhibit IL2 secretion induced by TCR/CD4/p56lck, emphasizing the specific action of FK506 and cyclosporin A.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522130     DOI: 10.1006/cimm.1994.1255

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  Modulation of NFAT-5, an outlying member of the NFAT family, in human keratinocytes and skin.

Authors:  Wael I Al-Daraji; John Afolayan; Bettina G Zelger; Adel Abdellaoui; Bernhard Zelger
Journal:  Am J Transl Res       Date:  2009-01-22       Impact factor: 4.060

Review 2.  Calcineurin-NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy.

Authors:  Kamila Bendickova; Federico Tidu; Jan Fric
Journal:  EMBO Mol Med       Date:  2017-08       Impact factor: 12.137

3.  T cell responses in calcineurin A alpha-deficient mice.

Authors:  B W Zhang; G Zimmer; J Chen; D Ladd; E Li; F W Alt; G Wiederrecht; J Cryan; E A O'Neill; C E Seidman; A K Abbas; J G Seidman
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

Review 4.  Cyclophilin A as a target in the treatment of cytomegalovirus infections.

Authors:  Ashwaq A Abdullah; Rasedee Abdullah; Zeenathul A Nazariah; Krishnan N Balakrishnan; Faez Firdaus J Abdullah; Jamilu A Bala; Mohd-Azmi Mohd-Lila
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.